Bioblast Pharma (ORPN) seeking strategic alternatives

  • June 7, 2017

Bioblast Pharma Ltd. (ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced that it has engaged JSB-Partners, a global life sciences advisor, to assist the Company in executing its business development objectives.